Luthi & Co (Herzog Patents)

Luthi & Co. (Herzog Patents)

Partner

Martin Binnes received his degree in pharmacy from the University of Bradford, England, in 1984, and worked for a year as a formulation scientist in Beecham. He then immigrated to Israel and worked in research and development and drug registration in the pharmaceutical industry for almost two decades before moving to intellectual property law at Luthi & Co. During this period, he obtained an LLB from Tel Aviv University and an LLM (magna cum laude) from the Free University of Brussels. His master’s thesis in international law dealt with new forms of intellectual property for pharmaceuticals.

Mr Binnes joined the firm in 2006 and specialises in complex pharmaceutical patent cases, where clients have found his outstanding scientific fundamentals and industry experience, as well as his practical perspective, to be valuable assets. His expertise in many scientific fields, particularly those pertaining to the pharmaceutical industry, has helped in raising even higher the firm’s outstanding ability to address even the most complicated scientific and technological issues involved in patent cases. Over the past few years, he has been involved in most of the firm’s most complicated patent cases, including the cases for Takeda, Gilead, Novartis, Merck Serono, GSK, Merck, Johnson & Johnson and many more.

English; Hebrew

B.Sc.Pharm, 1984, University of Bradford, England; LL.B., Tel Aviv University, Israel.